Sort by Year

Nosal DG, van Breemen RB, Haffner JW, Rubinstein I, and Feinstein DL. Brodifacoum pharmacokinetics in acute human poisoning: implications for estimating duration of vitamin K therapy. Toxicol Commun. 2021; 5(1): 69–72. doi: 10.1080/24734306.2021.1887637.

Muchiri RN, van Breemen RB. Affinity selection-mass spectrometry for the discovery of pharmacologically active compounds from combinatorial libraries and natural products. J. Mass Spectrom. 2021; 56(5):e4647. doi: 10.1002/jms.4647

Muchiri RN, van Breemen RB. Single laboratory validation of UHPLC-MS/MS assays for six milk thistle flavonolignans in human serum. J. AOAC Int. 2021; 104: 232-238. qsaa110,

Nosal DG, Feinstein DL, van Breemen RB. Chiral liquid chromatography-tandem mass spectrometry analysis of superwarfarin rodenticide stereoisomers – Bromadiolone, difenacoum and brodifacoum – In human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2021 Feb 15;1165:122529. doi: 10.1016/j.jchromb.2021.122529.

Heller GJ, Marshall MS, Issa Y, Marshall JN, Nguyen D, Rue E, Pathmasiri KC, Domowicz MS, van Breemen RB, Tai LM, Cologna SM, Crocker SJ, Givogri MI, Sands MS, Bongarzone ER. Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease. Mol. Ther. 2021; 29: 1883-1902. doi: 10.1016/j.ymthe.2021.01.026.

Gaba RC, Khabbaz RC, Muchiri RN, Morrison JD, Elkhadragy L, Totura WM, Samuelson JP, Whiteley HE, Deaton RL, Nguyen PL, Sverdlov M, Johnson JJ, van Breemen RB, Lokken RP. Conventional versus drug-eluting embolic transarterial chemoembolization with doxorubicin: comparative drug delivery, pharmacokinetics, and treatment response in a rabbit VX2 tumor model. Drug Deliv. Transl. Res. 2021 Apr 16. doi: 10.1007/s13346-021-00985-8.

Fança-Berthon P, Tenon M, Bouter-Banon SL, Manfré A, Maudet C, Dion A, Chevallier H, Laval J, van Breemen RB. Pharmacokinetics of a single dose of turmeric curcuminoids depends on formulation: Results of a human crossover study. J. Nutr. 2021; 151: 1802–1816.

Burton TCJ, Lankin DC, Nikolic D, Guo B, Ju J, Dietz BM, Che CT, Soejarto DD, van Breemen RB. Isolation and elucidation of two isoflavonoids from an American Indian plant, Amorpha canescens Pursh, using Magnetic Microbead Affinity Selection Screening (MagMASS) for estrogen receptor alpha ligands. Phytochem. Lett. 2021; 45: 110-116. doi: 10.1016/j.phytol.2021.07.018

van Breemen RB, Hafner JW, Nosal DG, Feinstein DL, Rubinstein I. Unmet clinical laboratory need in patients hospitalized for acute poisoning from long-acting anticoagulant rodenticides. Toxicol. Commun. 2021; 5(1): 93-96. doi: 10.1080/24734306.2021.1925444.

Ford HR, Busato S, Trevisi E, Muchiri RN, van Breemen RB, Bionaz M, Ates S. Effects of pasture type on metabolism, liver and kidney function, antioxidant status, and plant secondary compounds in plasma of grazing, Jersey dairy cattle during mid-lactation. Front. Anim. Sci. 2021; 2: doi: 10.3389/fanim.2021.729423

Molina J, Nikolic D, Jeevarathanam JR, Abzalimov R, Park EJ, Pedales R, Mojica EE, Tandang D, McLaughlin W, Wallick K, Adams J, Novy A, Pell SK, van Breemen RB, Pezzuto JM. Living with a giant, flowering parasite: metabolic differences between Tetrastigma loheri Gagnep. (Vitaceae) shoots uninfected and infected with Rafflesia (Rafflesiaceae) and potential applications for propagation. Planta. 2021; 255(1):4. doi: 10.1007/s00425-021-03787-x.

Muchiri RN, van Breemen RB. Drug discovery from natural products using affinity selection-mass spectrometry. Drug Discov. Today Technol. 2021; 40: 59-63. doi: 10.1016/j.ddtec.2021.10.005.

van Breemen RB, Newsome AG, Dahl, JH, Muchiri RN. Mass spectrometry and drug discovery. In Burger’s Medicinal Chemistry, Drug Discovery and Development. 8th Edition, Vol. 1:  Drug Discovery, ed. by Abraham DJ. John Wiley & Sons, NY, 2021.

Print Friendly, PDF & Email